Patents by Inventor Mark Justin IAMPIETRO

Mark Justin IAMPIETRO has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Recombinant adenoviruses and uses thereof
    Patent number: 11773142
    Abstract: Featured are recombinant adenoviruses and vectors thereof. In particular, the adenoviruses are simian (rhesus) adenoviruses having a low seroprevalence and high immunogenicity (when expressing, e.g., an antigenic polypeptide) relative to other adenoviruses and vectors thereof. Also featured are methods for producing the adenoviruses and methods of treatment of diseases by administering the adenoviral vector(s) to a subject (e.g., a human).
    Type: Grant
    Filed: December 11, 2018
    Date of Patent: October 3, 2023
    Assignee: Beth Israel Deaconess Medical Center, Inc.
    Inventors: Dan H. Barouch, Peter Abbink, Mark Justin Iampietro, Menzo J. E. Havenga
  • RECOMBINANT ADENOVIRUSES AND USES THEREOF
    Publication number: 20200399323
    Abstract: Featured are recombinant adenoviruses and vectors thereof. In particular, the adenoviruses are simian (rhesus) adenoviruses having a low seroprevalence and high immunogenicity (when expressing, e.g., an antigenic polypeptide) relative to other adenoviruses and vectors thereof. Also featured are methods for producing the adenoviruses and methods of treatment of diseases by administering the adenoviral vector(s) to a subject (e.g., a human).
    Type: Application
    Filed: December 11, 2018
    Publication date: December 24, 2020
    Inventors: Dan H. BAROUCH, Peter ABBINK, Mark Justin IAMPIETRO, Menzo J. E. HAVENGA